Page last updated: 2024-09-03

sb 200646 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

sb 200646 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies

Compound Research Comparison

Studies
(sb 200646)
Trials
(sb 200646)
Recent Studies (post-2010)
(sb 200646)
Studies
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Trials
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
24057930110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, T; Bunton, D; MacDonald, A; McGrath, JC; Shaw, AM; Tracey, A1

Other Studies

1 other study(ies) available for sb 200646 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

ArticleYear
5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
    Clinical science (London, England : 1979), 2000, Volume: 98, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Cattle; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Indoles; Lung; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Serotonin; Serotonin Antagonists; Urea; Vasoconstrictor Agents

2000